Accepting Immunotherapy After Multiline Treatment Failure: An Exploration of the Anxiety and Depression in Patients with Advanced Cancer Experience

BACKGROUND: Tumor immunotherapy is a promising therapeutic strategy for patients with advanced cancers, and some tumors have profound and durable tumor regression. However, immunotherapy is still in the clinical trial stage with elusive long-term effects and complications as a new strategy. It is un...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Qingqing, Sun, Caixia, Fei, Zhenghua, Yang, Xujing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743985/
https://www.ncbi.nlm.nih.gov/pubmed/35023904
http://dx.doi.org/10.2147/PPA.S346171

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743985/
https://www.ncbi.nlm.nih.gov/pubmed/35023904
http://dx.doi.org/10.2147/PPA.S346171

Ejemplares similares